Bank of Montreal’s Bristol-Myers Squibb BMY Stock Holding History

Bank of Montreal’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,000	Closed	-$182K	–	3860
2026 Q1	$182K	Buy	+3,000	New	+$175K	﹤0.01%	2961
2025 Q4	–	Sell	-50,000	Closed	-$2.25M	–	3614
2025 Q3	$2.25M	Buy	+50,000	New	+$2.34M	﹤0.01%	1599
2023 Q1	–	Sell	-150,000	Closed	-$11.9M	–	3803
2022 Q4	$11.9M	Hold	150,000	–	–	0.01%	908
2022 Q3	$10.8M	Hold	150,000	–	–	﹤0.01%	953
2022 Q2	$12.1M	Sell	150,000 -111,200	-43%	-$8.47M	0.01%	972
2022 Q1	$19.3M	Buy	+261,200	New	+$17.5M	0.01%	846
2021 Q2	–	Sell	-166,900	Closed	-$10.3M	–	3798
2021 Q1	$10.3M	Buy	166,900 +100,000	+149%	+$6.22M	0.01%	994
2020 Q4	$4.35M	Sell	66,900 -333,100	-83%	-$20.5M	﹤0.01%	1475
2020 Q3	$23.1M	Buy	+400,000	New	+$24.1M	0.02%	542
2020 Q2	–	Sell	-167,300	Closed	-$9.24M	–	4632
2020 Q1	$9.24M	Buy	167,300 +121,900	+269%	+$7.45M	0.01%	729
2019 Q4	$2.91M	Buy	+45,400	New	+$2.6M	﹤0.01%	1670
2018 Q3	–	Sell	-620,000	Closed	-$34.3M	–	4730
2018 Q2	$34.3M	Buy	+620,000	New	+$33.5M	0.03%	444

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of Montreal's BMY Position: Q2 2026 in Review

Bank of Montreal increased its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2026, buying an estimated $23.4M and bringing the position to 2,777,169 shares worth $160M. The position accounts for 0.05% of the portfolio, ranked #288.

Bank of Montreal first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $475M in Q4 2020. 2,530 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Bank of Montreal held 2,777,169 shares of Bristol-Myers Squibb worth $160M as of Q2 2026.
Bank of Montreal bought 408,084 Bristol-Myers Squibb shares in Q2 2026, an estimated $23.4M.
Bristol-Myers Squibb made up 0.05% of Bank of Montreal's portfolio in Q2 2026, its #288 holding.
Bank of Montreal first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Bank of Montreal's Bristol-Myers Squibb position peaked at $475M in Q4 2020.
2,530 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.